Publications
Specialty
Search
EP Lab Digest
07/03/2024
A cardiologist renowned as a health equity champion and an executive leader in workplace diversity and inclusion will lead the American Heart Association into 2025
EP Lab Digest
07/03/2024
Oversubscribed offering expected to generate $60 million in immediate gross proceeds for the Company. Warrants issued in the offering could generate up to an additional $66MM
EMSWorld
07/03/2024
The new documentary ‘Into the Unknown’ captures the grueling journey of modern-day paramedics and explores the challenges they face—both professional and personal.
Neurology
07/03/2024
Comorbid ADHD is common in people with Tourettes syndrome (TS), with what range of prevalence? In children with tics and ADHD, what treatment does not worsen tics and reduces ADHD symptoms? Find out!
Advances in Inflammatory Bowel Disease Network
07/03/2024
Dr Holubar explains how three-dimensional imaging of pouches can help to refine diagnoses of pouch complications.
Rheumatology & Arthritis
07/03/2024
Professor Iain McInnes of the University of Glasgow delves into the latest science on the importance of the interleukin-12 interleukin-17 axis in axial spondyloarthritis.
Psych Congress Network, Neurology, Pharmacy Learning Network
07/02/2024
The US Food and Drug Administration has issued a highly-anticipated decision: the approval of donanemab—to be marketed as Kisunla by manufacturer Eli Lilly—for the treatment of early Alzheimer disease.
Journal of Clinical Pathways
07/02/2024
According to findings presented at ASCO 2024, researchers found that high deductible health plans are associated with worse survival in cancer survivors.
Wound Care
07/02/2024
The DOJ charged Alexandra Gehrke and Jeffrey King of AZ with various counts of conspiracy, healthcare fraud, receiving kickbacks, and money laundering in connection with an alleged scheme to fraudulently bill Medicare $900MM for highly expensive amniotic allografts.
Wound Care
07/02/2024
BioStem Technology announced breakthrough results with its AmnioWrap2 proprietary retention-processed amnion chorion (RE-AC) processing method vs a laminated process. RE-AC showed a greater percent area reduction (PAR) of DFUs of 67.3% vs 52.6% at 12 weeks and required fewer applications.
Wound Care
07/02/2024
Results of an AMSTAR-2 quality assessment of systematic reviews and meta-analyses regarding PRP in the treatment of venous ulcers found the evidence quality of the outcome measures as inadequate due to bias risk and imprecision. Wound Repair Regen
Wound Care
07/02/2024
A study of 32 patients with DFUs found the use of chitosan-based gel achieved a 92.0% reduction in wound surface area by week 10 with 4.62-fold higher odds of 75% wound closure vs placebo.BMJ Open Diab
Wound Care
07/02/2024
Guard Medical, Inc received FDA 510(K) clearance for NPseal under the product code OKO for Negative Pressure Wound Therapy Non-Powered Suction Apparatus. This new clearance increased the wear time of the NPseal device to 7 days from the previous 6 days.
Wound Care
07/02/2024
Foryou Medical, headquartered in China, received 510(k) clearance for LUOFUCON Collagen Particles, a native bovine powder dressing for the treatment of chronic wounds.
Wound Care
07/02/2024
A 24-patient RCT will compare using type-I collagen-based skin substitute vs dehydrated human amnion/chorion membrane for treatment of DFUs with primary outcome of percentage of wound reduction from weeks 1 through 4. Recruitment is ongoing with an estimated study completion date of Aug 2024. clinicaltrials.gov
Wound Care
07/02/2024
A 12-patient study assessed a new self-adhesive non-stretch compression garment compared to ASHIKA stockings (AS) on healthy patients and found that the static and dynamic stiffness were significantly higher in the new McBoooon product during movement. Ann Vasc Dis
Neurology
07/02/2024
The US Food and Drug Administration (FDA) rejected AbbVie’s ABBV-95 (foscarbidopa/foslevodopa) last week, raising concerns via complete response letter (CRL) regarding the inspection of a third-party manufacturer listed in the drug application.
First Report Managed Care
07/02/2024
While challenges such as vaccine safety, immunogenicity, and durability remain, ongoing research and clinical trials show promise for the development of effective RSV vaccines in the near future according to research compiled in the Official Journal of the Spanish Society of Chemotherapy.
Oncology
07/02/2024
At the 2024 ASCO Annual Meeting, Salomon Manier, MD, PhD, discusses data on teclistamab in combination with daratumumab and lenalidomide (DR) vs DR and dexamethasone as frontline therapy for patients with MM ineligible for transplant.
Psych Congress Network, Neurology
07/02/2024
Craig Chepke, MD, DFAPA, shares the importance of differentiating tardive dyskinesia (TD) from other movement disorders such as drug-induced Parkinsonism.